These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11567794)

  • 1. Effect of mercaptoethylguanidine scavengers of peroxynitrite on the development of experimental allergic encephalomyelitis in PLSJL mice.
    Scott GS; Kean RB; Southan GJ; Szabó C; Hooper DC
    Neurosci Lett; 2001 Sep; 311(2):125-8. PubMed ID: 11567794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An inhibitor of inducible nitric oxide synthase and scavenger of peroxynitrite prevents diabetes development in NOD mice.
    Suarez-Pinzon WL; Mabley JG; Strynadka K; Power RF; Szabó C; Rabinovitch A
    J Autoimmun; 2001 Jun; 16(4):449-55. PubMed ID: 11437493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors.
    Scott GS; Spitsin SV; Kean RB; Mikheeva T; Koprowski H; Hooper DC
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16303-8. PubMed ID: 12451183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform.
    Szabó C; Bryk R; Zingarelli B; Southan GJ; Gahman TC; Bhat V; Salzman AL; Wolff DJ
    Br J Pharmacol; 1996 Aug; 118(7):1659-68. PubMed ID: 8842429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoguanidine, a selective inhibitor of the inducible nitric oxide synthase, has different effects on experimental allergic encephalomyelitis in the induction and progression phase.
    Okuda Y; Sakoda S; Fujimura H; Yanagihara T
    J Neuroimmunol; 1998 Jan; 81(1-2):201-10. PubMed ID: 9521623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arachidonyl trifluoromethyl ketone ameliorates experimental autoimmune encephalomyelitis via blocking peroxynitrite formation in mouse spinal cord white matter.
    Vana AC; Li S; Ribeiro R; Tchantchou F; Zhang Y
    Exp Neurol; 2011 Sep; 231(1):45-55. PubMed ID: 21683698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct role of nitric oxide and peroxynitrite in mediating oligodendrocyte toxicity in culture and in experimental autoimmune encephalomyelitis.
    Li S; Vana AC; Ribeiro R; Zhang Y
    Neuroscience; 2011 Jun; 184():107-19. PubMed ID: 21511012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evidence for a role of nitric oxide in experimental allergic encephalomyelitis: aminoguanidine treatment modifies its clinical evolution.
    Pozza M; Bettelli C; Aloe L; Giardino L; Calzà L
    Brain Res; 2000 Feb; 855(1):39-46. PubMed ID: 10650128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis.
    Hooper DC; Spitsin S; Kean RB; Champion JM; Dickson GM; Chaudhry I; Koprowski H
    Proc Natl Acad Sci U S A; 1998 Jan; 95(2):675-80. PubMed ID: 9435251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mercaptoethylguanidine and guanidine inhibitors of nitric-oxide synthase react with peroxynitrite and protect against peroxynitrite-induced oxidative damage.
    Szabó C; Ferrer-Sueta G; Zingarelli B; Southan GJ; Salzman AL; Radi R
    J Biol Chem; 1997 Apr; 272(14):9030-6. PubMed ID: 9083027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The acute and chronic phases of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE) are ameliorated by the peroxynitrite decomposition catalyst, 5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrinatoiron (III) chloride, (FeTPPS).
    Bolton C; Scott GS; Smith T; Flower RJ
    Eur J Pharmacol; 2008 Dec; 601(1-3):88-93. PubMed ID: 18977216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of peroxynitrite- and hypochlorous acid-induced inactivation of alpha1-antiproteinase by mercaptoethylguanidine.
    Whiteman M; Szabó C; Halliwell B
    Br J Pharmacol; 1999 Apr; 126(7):1646-52. PubMed ID: 10323598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of nitric oxide synthase by arginase and methylated arginines during the acute phase of experimental multiple sclerosis.
    Ljubisavljevic S; Stojanovic I; Pavlovic R; Sokolovic D; Pavlovic D; Cvetkovic T; Stevanovic I
    J Neurol Sci; 2012 Jul; 318(1-2):106-11. PubMed ID: 22507752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of mercaptoethylguanidine, a selective inhibitor of inducible nitric oxide synthase, in ligature-induced periodontitis in the rat.
    Lohinai Z; Benedek P; Fehér E; Györfi A; Rosivall L; Fazekas A; Salzman AL; Szabó C
    Br J Pharmacol; 1998 Feb; 123(3):353-60. PubMed ID: 9504374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences of inducible nitric oxide production in SJL/J mice with experimental autoimmune encephalomyelitis.
    Ding M; Wong JL; Rogers NE; Ignarro LJ; Voskuhl RR
    J Neuroimmunol; 1997 Jul; 77(1):99-106. PubMed ID: 9209274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxynitrite decomposition catalysts prevent myocardial dysfunction and inflammation in endotoxemic rats.
    Lancel S; Tissier S; Mordon S; Marechal X; Depontieu F; Scherpereel A; Chopin C; Neviere R
    J Am Coll Cardiol; 2004 Jun; 43(12):2348-58. PubMed ID: 15193704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis.
    Hooper DC; Bagasra O; Marini JC; Zborek A; Ohnishi ST; Kean R; Champion JM; Sarker AB; Bobroski L; Farber JL; Akaike T; Maeda H; Koprowski H
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2528-33. PubMed ID: 9122229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform.
    Southan GJ; Zingarelli B; O'Connor M; Salzman AL; Szabó C
    Br J Pharmacol; 1996 Feb; 117(4):619-32. PubMed ID: 8646406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis.
    Hooper DC; Scott GS; Zborek A; Mikheeva T; Kean RB; Koprowski H; Spitsin SV
    FASEB J; 2000 Apr; 14(5):691-8. PubMed ID: 10744626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scavenging of peroxynitrite reduces renal ischemia/reperfusion injury.
    Guven A; Uysal B; Akgul O; Cermik H; Gundogdu G; Surer I; Ozturk H; Korkmaz A
    Ren Fail; 2008; 30(7):747-54. PubMed ID: 18704824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.